Board of Directors

The Board of Directors is the ultimate governing authority of the American Diabetes Association. It exercises fiduciary oversight of our financial, ethical and legal affairs and ensures the organization's stability and viability to fulfill our mission.


Janel Wright, JD
Chair of the Board
Anchorage, AK

Chief of Adjudications
State of Alaska, Department of Labor & Workforce Development


David G. Marrero, PhD
President, Health Care & Education
Indianapolis, IN

J. O. Ritchey Endowed Professor of Medicine Director, Diabetes Translational Research Center
Indiana University School of Medicine


Samuel Dagogo-Jack, MD
President, Medicine & Science
Memphis, TN

Professor of Medicine & Director Division of Endocrinology, Diabetes & Metabolism A.C. Mullins Chair in Translational Research
University of Tennessee Health Science Center


Richard Farber, MBA
Secretary / Treasurer
Los Angeles, CA

Managing Partner
McKendree Capital


Robin J. Richardson
Chair of the Board-Elect
Portland, OR

Senior Vice President
Moda Health


Margaret Powers, PhD, RD, CDE
President-Elect, Health Care & Education
Minneapolis, MN

Research Scientist
International Diabetes Center


Desmond Schatz, MD
President-Elect, Medicine & Science
Gainesville, FL

Professor and Associate Chairman of Pediatrics Medical Director, Diabetes Center Director
Clinic Research Center at the University of Florida


Lorrie W. Liang
Secretary/ Treasurer-Elect
Baltimore, MD

Vice President
Sinai Hospital of Baltimore


Brian Bertha, JD, MBA
South San Francisco, CA

Chief Operating Officer
Crescendo Bioscience


David A. DeMarco, PhD
Iselin, NJ

Northeast Life Sciences Leader
Ernst & Young LLP


Felicia Hill-Briggs, PhD, ABPP
Baltimore, MD

Associate Professor of Medicine, Division of General Internal Medicine
Director, Behavior & Cognition Sub-Core, Healthcare and Population Science, Baltimore Diabetes Research Center
Senior Director, Population Health Research and Development, Johns Hopkins HealthCare
Johns Hopkins University School of Medicine


Jeffrey Himmel, MS
Miami, FL

Chairman and Chief Executive Officer
The Himmel Group


Alvin C. Powers, MD
Nashville, TN

Joe C. Davis Chair in Biologic Science Professor of Medicine, Molecular Physiology and Biophysics Director, Vanderbilt Diabetes Chief, Vanderbilt Division of Diabetes, Endocrinolgoy and Metabolsim Director, Vanderbilt Diabetes Research and Training Center
Vanderbilt University School of Medicine


Jane Reusch, MD
Denver, CO

Professor of Medicine, Biochemistry & Bioengineering
Associate Director, Center for Women’s Health Research
University of Colorado School of Medicine at the Anschutz Medical Campus
Director, VA Diabetes Team and CCTSI Liaison, Denver VAMC
University of Colorado and Denver VAMC


Calvin Schmidt, MBA
Raritan, NJ

President, Cardiovascular & Metabolism
Janssen Pharmaceuticals, Inc.


Catherine Squires, CFRE
Boston, MA

Vice President of Development, Tufts Medical Center Trust
Tufts Medical Center and Floating Hospital for Children


Umesh Verma
Houston, TX

Chief Executive Officer
BLUE LANCE


Alan L. Yatvin, JD
Philadelphia, PA

Managing Partner
Popper & Yatvin

Staff


Suzanne Berry, MBA, CAE
Interim Chief Executive Officer
Alexandria, VA